×

Do you want to link to this External Site and leave Amgen.com?

YOU ARE NOW LEAVING AMGEN'S WEB SITE. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

Press Release

View printer-friendly version
Patricia Sueltz Elected to Amgen's Board of DirectorsTHOUSAND OAKS, Calif., Jan 8, 2002 -- Amgen (Nasdaq: AMGN) announced today that it has elected Patricia Sueltz, executive vice president and general manager of Sun Microsystems Software Systems Group, to its board of directors.

"Patricia Sueltz's experience in managing fast-growing, information intensive companies will be important to Amgen as we grow and become more information management dependent ourselves," said Kevin Sharer, Amgen's chairman and chief executive officer.

At Sun, Sueltz is responsible for all aspects of the company's software systems business, including Java/XML, Solaris and the Sun Developer Network. As one of the top operating executives, she reports to Sun's president and chief operating officer. Prior to joining Sun in 1999, Sueltz held various senior management positions at IBM Corporation.

Sueltz is a member of the board of directors of Delphi Automotive Systems, a director of the Sun Microsystems Foundation Board, a member of the corporate advisory council for the University of Southern California's Marshall School of Business and the Enterprise Software Roundtable Advisory Board. She holds a BA from Occidental College and was a Rockefeller Fellow at the Claremont School of Theology and Ethics.

This appointment brings the number of directors of Amgen's board to 12.

Amgen is a global biotechnology company that discovers, develops, manufactures and markets important human therapeutics based on advances in cellular and molecular biology.

CONTACT: Amgen, Thousand Oaks
Jeff Richardson, 805/447-3227 (media)
Cary Rosansky, 805/447-4634 (investors)